Beas-Zarate C - Search Results

1

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.

Folch J, Ettcheto M, Busquets O, Sánchez-López E, Castro-Torres RD, Verdaguer E, Manzine PR, Poor SR, García ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A. Folch J, et al. Pharmaceuticals (Basel). 2018 Jan 29;11(1):11. doi: 10.3390/ph11010011. Pharmaceuticals (Basel). 2018. PMID: 29382127 Free PMC article. Review.

2

Inhibition of ataxia telangiectasia-p53-E2F-1 pathway in neurons as a target for the prevention of neuronal apoptosis.

Camins A, Verdaguer E, Folch J, Beas-Zarate C, Canudas AM, Pallàs M. Camins A, et al. Curr Drug Metab. 2007 Oct;8(7):709-15. doi: 10.2174/138920007782109814. Curr Drug Metab. 2007. PMID: 17979659 Review.

3

Effects of MPP+ on the molecular pathways involved in cell cycle control in B65 neuroblastoma cells.

Pizarro JG, Junyent F, Verdaguer E, Jordan J, Beas-Zarate C, Pallàs M, Camins A, Folch J. Pizarro JG, et al. Pharmacol Res. 2010 May;61(5):391-9. doi: 10.1016/j.phrs.2010.01.003. Epub 2010 Jan 18. Pharmacol Res. 2010. PMID: 20080185

4

An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders.

Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Beas-Zarate C, Pallas M. Camins A, et al. Expert Opin Investig Drugs. 2010 May;19(5):587-604. doi: 10.1517/13543781003781898. Expert Opin Investig Drugs. 2010. PMID: 20402598 Review.

5

Sirtuin activators: designing molecules to extend life span.

Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Pelegri C, Vilaplana J, Beas-Zarate C, Pallàs M. Camins A, et al. Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):740-9. doi: 10.1016/j.bbagrm.2010.06.005. Epub 2010 Jun 23. Biochim Biophys Acta. 2010. PMID: 20601277 Review.

6

Prosurvival role of JAK/STAT and Akt signaling pathways in MPP+-induced apoptosis in neurons.

Junyent F, Alvira D, Yeste-Velasco M, de la Torre AV, Beas-Zarate C, Sureda FX, Folch J, Pallàs M, Camins A, Verdaguer E. Junyent F, et al. Neurochem Int. 2010 Dec;57(7):774-82. doi: 10.1016/j.neuint.2010.08.015. Epub 2010 Sep 9. Neurochem Int. 2010. PMID: 20817061

7

Microarray analysis of rat hippocampus exposed to excitotoxicity: reversal Na(+)/Ca(2+) exchanger NCX3 is overexpressed in glial cells.

Ortuño-Sahagún D, Rivera-Cervantes MC, Gudiño-Cabrera G, Junyent F, Verdaguer E, Auladell C, Pallàs M, Camins A, Beas-Zárate C. Ortuño-Sahagún D, et al. Hippocampus. 2012 Feb;22(2):128-40. doi: 10.1002/hipo.20869. Epub 2010 Oct 6. Hippocampus. 2012. PMID: 20928830

8

Gene expression profile in JNK3 null mice: a novel specific activation of the PI3K/AKT pathway.

Junyent F, de Lemos L, Verdaguer E, Folch J, Ferrer I, Ortuño-Sahagún D, Beas-Zárate C, Romero R, Pallàs M, Auladell C, Camins A. Junyent F, et al. J Neurochem. 2011 Apr;117(2):244-52. doi: 10.1111/j.1471-4159.2011.07195.x. Epub 2011 Feb 24. J Neurochem. 2011. PMID: 21255018 Free article.

9

Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells.

Pizarro JG, Folch J, Junyent F, Verdaguer E, Auladell C, Beas-Zarate C, Pallàs M, Camins A. Pizarro JG, et al. Apoptosis. 2011 May;16(5):536-50. doi: 10.1007/s10495-011-0583-3. Apoptosis. 2011. PMID: 21424556

10

Study of the pathways involved in apoptosis induced by PI3K inhibition in cerebellar granule neurons.

Vazquez de la Torre A, Junyent F, Folch J, Pelegrí C, Vilaplana J, Auladell C, Beas-Zarate C, Pallàs M, Camins A, Verdaguer E. Vazquez de la Torre A, et al. Neurochem Int. 2011 Aug;59(2):159-67. doi: 10.1016/j.neuint.2011.03.027. Epub 2011 Jun 6. Neurochem Int. 2011. PMID: 21683105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page